Evaluation of the Risk Factors and Clinical Features of Stroke in correlation with CT Scan findings by Kumaresan, R
 A Dissertation on 
EVALUATION OF THE RISK FACTORS AND CLINICAL 
FEATURES OF STROKE IN CORRELATION WITH  
CT SCAN FINDINGS  
Submitted to  
THE TAMILNADU DR. M.G.R. MEDICAL UNIVERISTY  
CHENNAI – 600 032 
 
In partial fulfillment of the regulations  
For the Award of the Degree of  
 
M.D. (GENERAL MEDICINE) 
BRANCH -1, PART - II 
 
KILPAUK MEDICAL COLLEGE  
CHENNAI – 600 010 
 
MARCH - 2007 
  
  
ACKNOWLEDGMENT  
I greatfully acknowledge and sincerely thank  
Prof. THIAGAVALLI KIRUBAKARAN, M.D., Dean, Govt. Kilpauk Medical 
College and Prof. D.S. SOMASEKAR, M.D., Superintendent Govt. Royapettah 
Hospital Chennai, for permitting me to utilize the facilities available in the 
institution for my study.  
 I owe my sincere gratitude to Prof. S.R. SAKUNTHALA, M.D., Professor 
and Head, Department of Internal Medicine, Kilpauk Medical College, for her 
constant encouragement and guidance in all stages of this study.  
 I whole heartedly express my sincere thanks to my respected chief Prof. 
G. RAJENDRAN, M.D., Reader in Medicine, Chief IInd Medical Unit, Govt. 
Royapettah Hospital, Kilpauk Medical College, for his valuable guidance and 
support throughout my dissertation work.  
 I wish to thank Dr. T. RAVINDRAN, M.D., Dr. A. NASREEN BEGUM, 
M.D., and Dr. T. RAMESHKUMAR, M.D., Assistant Professors, Department of 
Internal Medicine, Kilpauk Medical College, for their valuable suggestions and 
help rendered throughout this work.  
 I also extend my thanks to Dr. AMUDHAN, Assistant Professor, 
Department of Radiology, Govt. Royapettah Hospital, for his kind and timely 
support.  
  I also thank my colleagues, house surgeons, staffs of our hospital for their 
contribution to the study. 
 Last but not least, with sincere gratitude, I thank all the patients who 
contributed so much to this study, without whom the study could not have been 
possible.  
 
 
 
  
CONTENTS 
S.NO. TITLE  PAGE NO. 
1. INTRODUCTION 1 
2. AIM OF THE STUDY 3 
3. REVIEW OF LITERATURE  4 
4. MATERIALS AND METHODS  43 
5. OBSERVATIONS AND RESULTS  46 
6. ANALYSIS OF DATA AND DISCUSSION  52 
7. CONCLUSION 67 
 BIBLIOGRAPHY   
 PROFORMA  
 ABBREVIATIONS   
 MASTER CHART  
   
 
  
 
 
 
 
 
 
 
Introduc
tion 
 INTRODUCTION 
 Cerebrovascular accident or stroke is one among the three leading causes 
of death, surpassed only by ischemic heart disease and malignancy. Stroke is 
also a common cause of physical disability, which imposes a substantial burden 
to the community in the foreseeable future. It is estimated that the incidence of 
stroke is likely to increase by about 20% in the next 20 years. In a developing 
nation like India, Rheumatic heart disease forms a significant risk factor for 
stroke. The high incidence and serious consequences make it one of the most 
important challenges faced by medical profession today. 
 Atleast 50 percent of the neurological disorders in a general hospital are 
due to stroke. As remarked by a renowned neurologist C.M. Fisher, neurology is 
learnt “Stroke by Stroke”. The advent of imaging procedures such as 
Computerized Tomography, Magnetic Resonance Imaging, Carotid Doppler and 
Magnetic Resonance Angiography have led to better evaluation of stroke and its 
risk factors.  
 A risk factor is a characteristic for an individual or for a population, 
indicating that the individual or population has an increased risk of stroke 
compared with one without that characteristic. Such an association does not 
imply causality which is determined more by strength of the association, the 
consistency of the association in different studies and population and the 
presence of a dose response relationship.  
  The last decade has witnessed exciting advances in the field of stroke, 
both in terms of enhanced understanding and in the availability of a rich panoply 
of therapeutic options, most important being thrombolytic therapy. Several 
studies in the recent years, have proved beyond doubt, the role of thrombolytic 
therapy in acute cerebral infarction. The success of this modality of treatment 
rests in early recognition of stroke and institution of therapy, for which a good 
knowledge of risk factors and clinical presentation of stroke and investigative 
modalities available is crucial.  
 Inspite of revolutionary changes in the management of ischemic stroke, 
the ultimate goal should be its prevention in order to decrease the incidence, for 
which, a thorough understanding of the etiopathogenesis and risk factors seems 
essential. 
Hence, the present study on stroke was undertaken.  
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AIM OF THE STUDY 
 
1. To study the age and gender distribution. 
2. To evaluate the risk factors in cerebrovascular disease.  
3. To study the mode of presentation of different types of stroke.  
4. To study the pathogenesis of stroke with the aid of CT Scan. 
5. Correlative study of the above modalities.  
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 REVIEW OF LITERATURE 
STROKE (Synonyms: Cerebrovascular Accident, Apoplexy) 
DEFINITIONS  
Stroke 
 WHO defined stroke as “rapidly developed clinical signs of focal or 
global disturbance of brain function; lasting more than 24 hrs or leading to death, 
with no apparent cause other than vascular origin”.  
Completed Stroke 
 It is the term applied to the temporal profile of the stroke syndrome in 
which the deficit is prolonged and often permanent, causing demonstrable 
parenchymatous changes. Most completed strokes reach the maximum of 
neurological dysfunction within an hour of onset.  
Stroke in Evolution  
 This describes the temporal profile in which the neurological deficit 
occurs in a stepwise or progressive fashion culminating in a major deficit in the 
absence of treatment. In the carotid arterial system, this progression may go upto 
24 hrs. If the vertebrobasilar system is the site of ischemia, the deficit may 
progress for upto 72 hours.  
Transient Ischemic Attack (TIA) 
  It is an acute loss of focal cerebral or monoocular function with 
symptoms lasting less than 24 hours, which after adequate investigation is 
presumed to be due to thrombotic or embolic vascular disease.  
Reversible Ischemic Neurological Deficit (RIND) 
 It is the term applied to the temporal profile of the stroke syndrome in 
which the focal neurological ischemic deficit lasts longer than 24 hours but 
resolves within 3 weeks. 
Stuttering Hemiplegia 
 It is characterized by repeated episodes of TIA or crescendo TIAs 
followed by fully evolved stroke. Internal carotid artery lesions produce this 
event.  
Lacunar Stroke 
 It is secondary to lipohyalinosis or microatheroma of the small 
perforating branches within the brain substance producing small deep infarcts 
less that 1.5 cm in diameter.  
 Pathological types of stroke 
1. Cerebral infarction – Cerebral thrombosis / embolism  
2. Primary Intracerebral haemorrhage  
3. Subarachnoid haemorrhage. 
EPIDEMIOLOGY OF STROKE 
 Stroke epidemiology has lagged behind coronary artery disease, since 
strokes are not only less frequent, but occur later in life.7 Stroke epidemiology is 
hampered by : 
 Diagnosis still being largely a matter of clinical skill, without help of 
many confirmatory investigations.  
 Being a disorder of late middle age and elderly, where other diseases 
frequently co-exist.  
 A low post-mortem rate.  
 Inaccuracy of death certificates.  
 Being more pathologically diverse.  
Incidence can only be reliably assessed in prospective community based 
studies using obsessional methodology to identify all possible patients. Hospital 
based studies are subject to referral bias since very mild and rapidly fatal strokes 
are least likely to be brought to the hospital. In any case, the incidence of stroke 
rises rapidly with age, about a quarter occur below the age of 65, and about a 
half below the age of 75. 
 Prevalence is difficult to measure because a large representative sample 
has to be identified as the denominator, a large proportion of that sample must be 
questioned and many past stroke episodes are forgotten by patients8. 
Prevalence depends on long-term survival which may be changing. In any 
event, stroke prevalence dose not even capture the burden of stroke since some 
patients die early after the onset and many of the survivors are not disabled at all. 
The mortality of stroke is on the decline in the recent years. However, it is 
unlikely that treatment of hypertension is responsible since the decline had 
started earlier and treatment cannot explain more than 25% of the decline9. 
Treatment of TIAs is also unlikely, largely because only a small proportion of 
strokes are preceded by TIAs10. Based on retrospective analysis of subjects 
admitted in urban hospitals in India, strokes constitute 2% of all hospital cases 
and 20% of neurological admissions. Incidence in younger population (below 40 
years) is 13-22%. 
 Seasonal and Diurnal Variation 
Stroke incidence and mortality is higher in winter months11, probably 
secondary to high blood pressure and complications like pneumonia being more 
fatal in winter12. 
Cerebral infarction occurs more frequently in an hour or two after waking 
in the morning13. Sub-arachnoid haemorrhage is unlikely to occur during sleep, 
whereas intracerebral haemorrhage is more likely to occur during strenuous 
activity. 
RISK FACTORS 
 Stroke places a tremendous burden on health resources throughout the 
world. Vast majority of stroke patients have well recognized risk factors, and 
reducing their prevalence should make a considerable impact on stroke 
incidence. Nonmodifiable risk factors include age, sex, race, genetic factors and 
family history. 
Age 
 Age is the strongest risk factor for stroke. Risk of stroke in people aged 
75-84 yrs is 25 times the risk in people age 45-54 yrs14. 
 Gender 
 There is a small male excess of strokes most prominent in middle age and 
disappearing in the very elderly and probably absent in the young12. However the 
difference is much less than that observed in myocardial infarction and 
peripheral vascular disease. It is more common in blacks than whites.  
Genetic factors 
 Some genetically determined diseases are vascular anomalies like 
malformations, aneurysms, connective tissue disorders such as Ehler – Danlos 
Syndrome, Marfan’s syndrome and hereditary causes of hypercholesterolemia. 
Several genetic determinants contribute to stroke risk. Of these, carotid intimal-
medial wall thickness (IMT) is particularly relevant, because it is a surrogate 
measure of subclincial atherosclerosis and a strong predictor of future ischemic 
stroke. Studies of twins, siblings, and families have provided significant 
evidence for heritability, but the genes involved have not been identified. Some 
researchers have reported that IMT is high in people with functional variants of 
genes related to matrix deposition (MMP3), inflammation (interleukin 6), and 
lipid metabolism (hepatic lipase, APOE, CETP, and PONI)15. 
Family history 
 Sometimes stroke is clearly familial in some cases it is a simple 
mendelian pattern of inheritance (eg. Hemophilia). Family history of stroke is an 
independent risk factor for ischemic stroke with onset before age 70 years16.  
 Modifiable / Preventable Risk Factors  
Systemic Hypertension 
 Systemic hypertension is strongly associated with stroke risk, probably by 
increasing the extent and severity of atheroma, and the prevalence of 
microvascular disease in the small penetrating arteries. Stroke risk doubles with 
each 7.5 mmHg increase in diastolic blood pressure. A reduction of blood 
pressure 10-12 mm systolic, 5-10 mmHg diastolic is associated with 38% 
decrease in stroke17. Isolated systolic hypertension (ISH) and isolated diastolic 
hypertension (IDH) both are independent predictors of stroke. Patients with 
systolic and diastolic hypetension both are at the highest risk of stroke and 
should be treated more aggressively18.  
 The strength of association of blood pressure and stroke is strong 
consistent, biologically plausible and treatment reduces stroke risk. Hence one 
can conclude that hypertension is a causal risk factor19,20. Hypertension and type 
2 diabetes increase stroke risk independently, and their combination increases 
the risk drastically. A significant proportion of the risk of stroke assumed to be 
related to hypertension may be attributable to concomitant diabetes21.  
Diabetes Mellitus 
 Diabetes doubles the risk of stroke compared to non-diabetics.20 In 
addition patients with diabetic retinopathy and autonomic neuropathy are at 
increased risk of ischemic stroke.22 Raised Hb A1c is an independent risk factor 
 for stroke in people with and without diabetes23. Impaired glucose tolerance is an 
independent risk factor for future stroke in nondiabetic patients with TIA or 
minor ischemic stroke24. 
Hyperlipidemia 
 Increased levels of plasma total cholesterol, LDL cholesterol and 
decreasing levels of HDL cholesterol are strong risk factors for coronary artery 
disease25. Although their relationship to stroke is less clearcut compared to 
ischemic heart disease, there is almost certainly some association. This may be 
due to lipid levels being less associated with vascular events in the elderly 
(where more strokes occur) than in younger people (where coronary events are 
more common26). Cholesterol levels are also negatively associated with 
haemorrhage27. 
Smoking 
 Smoking is a strong risk factor for subarachnoid haemorrhage28 (relative 
risk 3.0), and for cerebral infarction (relative risk 2.0) and there appears to be no 
association with parenchymal haemorrhage. Males and females are equally 
affected, but the association seems to be weaker in the elderly29. Stroke risk 
decreases 5 yrs after cessation of smoking. There is a positive association 
between history of smoking among spouses with the incidence of stroke30. 
Alcohol 
  Heavy consumption is an independent risk factor, while moderate 
consumption may be protective31. However, apoE genotype may modify this 
association, and even moderate alcohol intake may be associated with an 
increased risk of ischemic stroke among apoE4-positive older adults32. Drinking 
pattern and beverage type may also be important. Intake of more than 2 drinks 
per day may be associated with a higher risk for ischemic stroke33. Alcohol 
consumption also raises the blood pressure34, affects blood lipids35, increases the 
incidence of atrial fibrillation36 and cardiomyopathy which predispose to stroke.  
 Heart Disease 
 Coronary artery disease is clearly associated with stroke. The risk for 
stroke is markedly increased after MI, particularly early after MI, compared with 
the expected risk in population without MI. Stroke is associated with a large 
increase in the risk for death after MI37. Cardiac failure, ECG changes and rapid 
heart rate further increase the risk. Left ventricular dysfunction even of mild 
degree, is independently associated with an increased risk of ischemic stroke38. 
The most frequent potential cardiac cause of embolism is atrial fibrillation, 
usually non-rheumatic in developed countries, rheumatic in developing 
nations39. 
Transient Ischemic Attacks  
 TIAs are ischemic strokes, recovering in 24 hrs. A TIA patient has an 
increased risk of stroke about 5–10 times greater than that of a non TIA patient 
of the same age. The risk of stroke after initial stroke / TIA is higher than the 
risk of cardiac events. The propensity after stroke / TIA to have the first 
recurrent ischemic event in the brain, rather than in the heart, has implications 
for prophylactic therapy selection40. 
 Carotid Stenosis 
 Cervical carotid bruit is a risk factor for stroke, but not necessarily in the 
same arterial territory, because stenosis in one artery is likely to be associated 
with disease of other arteries41. Less than 75% occlusion has 1.3% annual 
incidence of stroke, while more than 75% occlusion has a risk of 10.5% per year. 
Ulcerated, echoluscent, heterogenous plaques with soft core are at higher risk. 
Aortic arch atheroma is an important independent risk factor for stroke, studies 
indicate a four times greater odds of stroke in patients with severe arch 
atheroma42. 
Haematocrit 
 Cerebral blood flow is strongly related to haematocrit. Increased 
haemotocrit in association with smoking, hypertension and plasma fibrinogen 
increase the risk of stroke. 
Hormones 
 Although strokes are uncommon in females of the reproductive age 
group, attributing this to endogenous sex hormones is difficult43, since high does 
estrogen given to elderly men with prostate cancer, increases risk of vascular 
event44. The use of oral contraceptive pills triples the risk of stroke in women 
especially smokers aged more than 30 years. 
  Hormone replacement therapy seems to have a protective effect45. It has 
been stated that natural menopause has no effect on stroke while surgical 
menopause without estrogen replacement doubles the risk. 
Obesity 
 The relationship between obesity and stroke is seldom studied, and if 
present is probably secondary to its association with hypertension and diabetes. 
The risk of stroke is increased in men with metabolic syndrome, in the absence 
of past history of stroke, diabetes and cardiovascular disease at baseline46. 
Diet  
 High salt intake47, decreased intake of fruits, vegetables48, deficiency of 
selenium and vitamin E are associated with increased risk, while high potassium 
diet by reducing blood pressure reduces risk of stroke49. 
 Other Risk Factors 
1. High serum uric acid levels are strong risk factor for stroke50. 
2. Severe obstructive sleep apnea syndrome increases the risk of ischemic 
stroke in elderly population and the increase is independent of other risk 
factors, including hypertension51, 52.  
3. Physical inactivity is associated with an increased risk of stroke. A high 
level of leisure time physical activity reduces the risk of all subtypes of 
stroke53. 
4. Chagas Disease is a risk factor for stroke, independent of systolic 
dysfunction or presence of cardiac arrhythmias54. 
5. Fabry Disease is also one of the cause of unexplained stroke in young 
patients, especially in those with the combination of infarction in the 
vertebrobasilar artery system and proteinuria55. 
6. Moyamoya Disease is a risk factor for stroke56. 
7. Higher serum ferritin concentrations in postmenopausal women are 
associated with an increased risk of ischemic stroke57. 
8. A high Lp(a) concentration is associated with a higher incidence of 
ischemic stroke in blacks and white women, but not in white men58. 
 9. Peripheral arterial disease is a strong marker of multifocal atherosclerotic 
disease. Individuals with intermittent claudication and asymptomatic 
peripheral vascular disease (as defined by an abnormal low ankle-brachial 
systolic pressure index) are at excess risk of stroke59. 
10. Raised plasma factor VII coagulant activity, raised tissue plasminogen 
activator antigen, low blood fibrinolytic activity and raised von 
Willebrand factor are risk factors for coronary artery disease and may also 
be risk factors for stroke60. 
11. Hyperhomocyteinaemia is a risk factor for stroke61. 
12. Oral contraceptives increase the risk of ischemic stroke, and less so, 
haemorrhagic strokes62. 
13. Arterial dissection  
14. Antiphospholipid syndrome  
15. Protein C, protein S deficiencies  
16. Other less documented risk factors include. 
 a.  Sickle cell disease  
 b.  Drug abuse  
 c.  Low socioeconomic factors  
 d.  Stress  
 e.  Alpha (1) antichymotrypsin polymorphism  
  f.  Boiled and unfiltered coffee consumption  
 g.  Pregnancy and puerperium  
 h.  Infection – Chlamydia pneumoniae, periodontal  disease, 
 meningeo vascular syphilis, Helicobacter  pylori. 
i. Cholesterol embolisation syndrome  
 j. Trauma  
 k. Fibromuscular dysplasia  
 l. Irradiation  
 PATHOPHYSIOLOGIC CLASSFICATION OF STROKE 
I.  ISCHEMIC – 85% 
 Thrombotic     Embolic  
Lacunar   20-25%  Cardioembolic  20% 
 Large Vessel  1-5%   Artery – artery  15%  
      Cryptogenic  30%   
     Others   10% 
II.  HAEMORRHAGIC – 15% 
 Intraparenchymal   - 10% 
 Subarachnoid    - 1-2% 
 Subdural     - <1% 
 Epidural     - <1%   
ISCHEMIC STROKE  
 Ischemic stroke is caused by a sudden occlusion of an artery supplying 
the brain or less often by low flow distal to an already occluded artery. The 
causes of ischemic stroke include: 
a. Thrombosis    
 Atherosclerosis   
 Vasculitis 
Collagen vascular disease: Temporal (Giant cell) arteritis, polyarteritis 
nodosa, Wegener’s granulomatosis, Takayasu’s arteritis, syphilis.  
 Meningitis: Tuberculous, fungi, syphilis, bacteria, herpes zoster  
Arterial dissection: Carotid, vertebral, intracranial arteries. 
Haematological disorders: Polycythemia, thrombocytosis, thrombotic 
thrombocytopenic purpura, DIC, dysproteinemias, haemoglobinopathies 
(sickle cell disease).  
Miscellaneous: Cocaine, amphetamine, moyamoya disease, fibromuscular 
dysplasia, Binswanger’s disease.  
 
b. Embolism  
 Cardiac Source  
 Dysrhythmia – Atrial fibrillation, sick sinus syndrome  
 Coronary artery disease 
 Rheumatic heart disease 
 Cardiomyopathy 
 Prosthetic valve  
 Congenital heart disease - MVP, patent foramen ovale 
 Infective endocarditis  
 Atrial myxoma  
  Non-bacterial thrombotic endocarditis. 
Atherothrombotic arterial disease  
Bifurcation of common carotid artery, distal vertebral artery and aortic 
arch. 
Unknown source  
May be associated with a hypercoagulable state 
c. Vasoconstriction  
 Following subarachnoid haemorrhage, migraine, eclampsia etc.  
d. Venous occlusion  
 Dehydration, post-partum, systemic cancer etc.  
 Brain is an obligate aerobe and obtains energy from oxidative metabolism 
of glucose. Since the brain glucose stores are negligible, a decrease in cerebral 
blood flow causes ischemia. The normal cerebral blood flow is 50 ml/100 g/min. 
When this falls below a critical value of 20 ml/100 g/min, there is loss of 
neuronal electronic function which is a reversible stage. When it decreases to 
less than 10 ml/100 g/min, then aerobic mitochondrial metabolism fails and 
anaerobic metabolism leads to lactic acidosis63. As a sequel, sodium and water 
enters the cell, potassium leaks out, due to failure of energy dependent 
intracellular homeostasis, leading to irreversible cell death.  
  In man, it is not known exactly how long and how severe focal ischemia 
has to be before complete recovery of function is impossible. The ischemic and 
infarcted brain cannot autoregulate. Therefore modest increase in cerebral 
perfusion pressure could cause hyperemia, increased cerebral blood flow, edema 
and haemorrhagic infarction which in turn increases intracranial tension and 
decreases cerebral perfusion pressure. On the other hand, a decrease in cerebral 
perfusion pressure may exacerbate ischemia.  
 Ischemic penumbra is an area around an infarcted tissue, that is in the 
reversible state of electrical failure, where flow is decreased, function depressed, 
oxygen extraction fraction is high, but recovery is still possible. Thrombolytic 
agents are used in this window time to salvage the ischemic penumbra zone.  
 Ischemic cerebral edema is partly cytotoxic and partly vasogenic. 
Cytotoxic edema starts within minutes and affects grey matter. Vasogenic edema 
starts several hours later and affects more white matter, since the damaged blood 
brain barrier allows plasma to enter the extracellular space.  
Differentiating signs of Thrombosis and Embolism 
Thrombosis    Embolism  
Preceding brief shot gun like TIA 
 
Single or infrequent but longer – 
lasting TIA or strokes  
TIAs all in same vascular territory  
 
 
Infarcts in multiple vascular territories  
 Onset of stroke after sleep Onset during activity or sudden strain, 
cough or sneeze.  
 
Absence of distal embolus by 
angiography 
Presence of distal intra arterial 
embolus by angiography or 
transcranial doppler  
 
Infarct on CT or MRI near border 
zone of affected artery  
Infarct on CT or MRI in heart of 
vascular territory wedge shaped and 
abutting on cortical surface 
 
Presence of risk factors for 
atherosclerosis  
 
Presence of known cardiac, arterial or 
venous source of embolus  
Occlusion or severe stenosis of a 
large artery shown by USG or 
angiography 
 
Haemorrhagic cerebral infarct on CT 
 HAEMORRHAGIC STROKE  
 Intracranial haemorrhage accounts for approximately 15% strokes. The 
overall mortality for this subtype of stroke is from 25% to 60%. In nearly 70% of 
patients hypertension is the commonest cause. Other causes include 
arteriovenous malformation, aneurysm, coagulopathy, drugs, amyloid 
angiopathy, metastatic tumours, cavernous angiomas, dural arterial-venous 
fistula, capillary telangiectasia –etc.  
Location of hypertensive haemorrhage :  
 Putamen     - 60 – 65% 
 Thalamus     - 15 - 25% 
 Pons      - 5 - 10% 
 Cerebellum     - 1 – 5% 
 Subcortical white matter  - 1 – 2% 
 Clinical presentation of intracranial haemorrhage are mainly due to 
symptoms of raised intracranial tension and specific for the location of 
haematoma. Characteristically haemorrhage presents with progression of deficits 
over a period of hours. Seizures at the time of presentation occurs usually in 
cortical haemorrhage.  
 CT continues to be the gold standard for diagnosis of acute intracranial 
haemorrhage and evaluating its prognosis. MRI appears normal in the first 24 
hrs, but is more specific than CT in determining the age of haemorrhage. Acute 
 haemorrhage appears as a hyperdense area having attenuation values of 50-100 
Hounsfeld units. They become hypodense in the ensuring couple of weeks. The 
periphery of the clot is absorbed at a rate of 0.7 mm/day. 
SUBARACHNOID HAEMORRHAGE [SAH] 
 The incidence of SAH increases with age being more common in women. 
Causes include rupture of a saccular aneurysm, bleeding from vascular anomaly, 
extension into subarachnoid space from primary intracerebral haemorrhage. 
Idiopathic SAHs are localized to perimesencephalic cisterns and are benign64. 
Chronic, recurrent bleed produces superficial hemosiderosis of central nervous 
system65.  
 SAH usually presents as excruciating headache followed by loss of 
consciousness. Focal neurologic deficits such as hemiparesis, aphasia, abulia 
may occur. Delayed neurological deficits may be due to  
re-rupture, hydrocephalus, vasospasm and hyponatremia.  
 Hall mark of SAH is blood in CSF. High quality, non-contrast CT 
localizes blood in 95% of cases within 72 hrs. Lumbar puncture is indicated only 
if CT scan is not available. Four-vessel conventional  
X-ray angiography is performed to localize, define anatomic details for 
interventional therapy.  
INTRACRANIAL VENOUS THROMBOSIS  
  Thrombosis in dural sinuses /cerebral veins is much less common than 
arterial thrombosis. However, it should be suspected in high risk groups mainly 
postpartum and malignancies. Venous thrombosis can result from diseases that 
alter clotting factor or cellular constituents of blood.  
CAUSES  
Local Systemic  
Head injury  Dehydration  
Intracranial surgery  Septicaemia  
Sepsis  Oral contraceptives  
Subdural empyema  Hypercoagulable states  
Meningitis  Drugs 
Tumor invasion of sinuses  
 
Catheterization of jugular vein 
Non- metastatic effect of 
intracranial malignancy  
 Symptoms depend on structure involved, extent and rapidity of 
thrombosis and collaterals. Headache, nausea, vomiting, convulsions, depressed 
alertness are frequent. Focal signs may be subtle or absent, but papilledema and 
meningeal signs are often found. Cavernous sinus thrombosis following 
infection of orbit, paranasal sinus produce orbital signs. Cerebral angiography is 
the definitive indication. Mortality is 15–30%, mainly results from cerebral 
 edema and secondary haemorrhagic infarction. Heparinization improves 
prognosis.  
STROKE IN THE YOUNG  
 Ischemic stroke is often considered as a disease of middle aged and 
elderly persons but it does occur in patients aged 40 years or less. This may be 
due to improved recognition and increased prevalence of risk factors. 
Predominant causes are: 
• Cardiovascular: Rheumatic heart disease, infective endocarditis, 
prosthetic valve, myxoma, mitral valve prolapse etc.  
• Non–atherosclerotic vasculopathies: Tuberculosis, syphilis, collagen 
vascular disease, dissection, trauma, migraine etc.  
• Hypercoagulable states: Ranging from disturbances in blood 
components, coagulation factors, platelet functions and deficiencies of 
clotting inhibitors or fibrinolytic system predispose to stroke.  
• Atherosclerosis: May occur prematurely secondary to earlier onset of 
risk factors such as hypercholesterolemia, smoking, diabetes mellitus, 
hypertension.  
Blood supply to the brain95  
 The blood supply to the brain is delivered by the two internal carotid and 
two vertebral arteries which anastomose at the base of the brain to form the 
circle of Willis. The carotid artery system supplies the anterior two-thirds of the 
 brain (hence it is called the anterior circulation) (Fig.1). The vertebrobasilar 
arterial system supplies the posterior third of the brain (hence it is called the 
posterior circulation) (Fig.2).  
 FIGURE - 1 
 
 
 
 
 
The anatomy of the arterial blood supply to the brain. Sites that are most often 
affected by atherosclerosis are shown as dark indentations in the arterial 
lumen. 
  
FIGURE – 2 
 
 
 
 
 
 
 
Diagrammatic representation of the circle of Willis at the base of the 
brain, as seen from below in relation to the optic chiasma. 
 STROKE SYNDROMES 95 
Internal carotid artery territory (or) anterior circulation stroke95 
Branches Region supplied Syndrome caused by ischemia 
Ophthalmic artery  Retina and optic nerve  Monoocular blindness or 
altitudinal field detect  
Anterior choroidal 
artery  
Globus pallidus 
internal capsule 
choroid plexus  
Contralateral hemiparesis, 
hemisensory loss and 
homonymous hemianopia  
 
Middle cerebral 
artery  
Frontal lobe  Contralateral facial weakness, 
hemiparesis and hemisensory loss 
(arm>leg), homonymous 
hemianopia, and global aphasia 
(dominant hemisphere) or visual-
spatial – perceptual dysfunction 
(non-dominant hemisphere) 
Medial 
lenticulostriate 
artery  
 
Internal capsule  Contralateral pure motor 
hemiparesis  
Lateral 
lenticulostriate 
artery  
Putamen, globus 
pallidus, caudate 
nucleus, internal 
capsule, corona 
radiata  
Contralateral hemiparesis, 
dysphasia (dominant hemispehre) 
or visual –spatial – perceptual 
dysfunction (non-dominant 
hemisphere) 
 
Superior division of 
middle cerebral 
artery  
Prerolandic branch  
Frontal and anterior 
parietal lobes  
Contralateral central facial 
weakness, hemiparesis and 
hemisensory loss, ipsilateral 
deviation of head and eyes, and 
global or motor aphasia (dominant 
hemisphere) Contralateral face and 
 Branches Region supplied Syndrome caused by ischemia 
Rolandic branch  
Anterior parietal 
branch  
arm weakness, and motor aphasia 
(dominant hemisphere) 
Contralateral central facial 
weakness, hemiparesis and 
hemisensory loss, and dysarthria 
(resembling lacunar syndrome) 
conduction aphasia and bilateral 
ideomotor apraxia  
Inferior division of 
middle cerebral 
artery  
Posterior parietal 
branch 
Angular branch  
Posterior temporal 
branch 
Anterior temporal 
branch 
Temporal polar 
branch  
 
Inferior parietal and 
lateral temporal lobes  
 
Homonymous hemianopia, 
Wernicke’s aphasia or agitated 
confusional state (dominant 
hemisphere), left visual neglect 
(right-sided lesion) 
Anterior cerebral 
artery  
 
Anterior and superior 
medial frontal lobe 
Contralateral foot and leg 
weakness or hemiparesis 
(leg>arm), abulia, incontinence, 
grasp reflexes  
 Vertebrobasilar territory (or) posterior circulation stroke95 
Branches Region 
supplied Syndrome caused by ischemia 
Vertebral and basilar 
artery  
Brainstem and 
cerebellum  
Various syndromes including: 
diplopia, ophthalmoplegia or gaze 
palsies; vertigo, nausea and 
nystagmus; dysarthria, dysphagia 
and bulbar weakness; ipsilateral 
facial sensory loss and weakness 
(nuclear or infranuclear); hiccups 
and respiratory failure contralateral 
hemiparesis or tetraparesis; 
contralateral or bilateral sensory 
loss; coma  
Basilar artery  
Top of basilar artery  
Rostral 
midbrain  
Part of 
thalamus  
Inferior 
temporal 
occipital lobes  
Variable pupillary abnormalities  
Ptosis or lid retraction  
Supranuclear vertical gaze paresis  
Somnolence  
Hemiballismus  
Amnesia  
Cortical blindness 
Superior cerebellar 
artery  
Midbrain 
(dorsolateral)  
Superior 
cerebellar 
peduncle  
Superior 
cerebellum  
Ipsilateral Horner’s syndrome 
Ipsilateral limb ataxia and tremor  
Contralateral spinothalamic sensory 
loss 
Contralateral central facial weakness 
Sometimes contralateral IVth nerve 
palsy  
Anterior inferior 
cerebellar artery  
Base of pons 
Rostral medulla  
Inferior 
cerebellum 
Cochlea  
Ipsilateral Horner’s syndrome  
Ipsilateral facial sensory loss  
(pain, temperature) 
Ipsilateral nuclear facial and 
abducens palsy 
 Branches Region 
supplied Syndrome caused by ischemia 
Vestibule  abducens palsy 
Ipsilateral deafness and tinnitus  
Vertigo, nausea, vomiting and 
nystagmus 
Ipsilateral ataxia of limbs and 
dysarthria  
Posterior inferior 
cerebellar artery  
Lateral medulla 
Inferior 
cerebellum  
Ipsilateral Horner’s syndrome  
Ipsilateral facial sensory loss (pain, 
temp) 
Vertigo, nausea, vomiting and 
nystagmus  
Ipsilateral paralysis of palate 
(dysphagia) 
Ipsilateral paralysis of larynx 
(dysphonia) 
Ipsilateral ataxia of limbs  
Contralateral hemisensory loss 
below neck 
Paramedian branches  Paramedian 
pons  
Any of the lacunar syndromes:  
Pure motor hemiparesis 
Pure hemisensory loss  
Hemiparesis – hemisensory loss  
Ataxic hemiparesis  
Internuclear ophthalmoplegia  
Locked- in syndrome, if bilateral  
Thalamic – subthalamic 
(Thalamoperforating) 
Posteromedial 
thalamus 
inferiorly 
Hemisensory loss, amnesia  
Paramedian 
mesencephalic arteries 
Rostral medial 
midbrain 
Hemisensory-motor loss 
 Branches Region 
supplied Syndrome caused by ischemia 
Posterior cerebral artery Occipital lobe 
inferior 
temporal lobe 
Contralateral homonymous 
hemianopia  
Cortical blindness if bilateral 
Amnesia (especially if bilateral) 
Thalamogeniculate  Ventrolateral 
thalamus 
Pure hemisensory loss 
Posterior choroidal 
arteries 
Anterior and 
posterior 
thalamus 
Hemisensory loss, amnesia 
Posterior 
communicating artery. 
Polar arteries 
(tuberothalamic) 
Anterior lateral 
thalamus 
Hemisensory loss, amnesia 
 
  
Lacunar Stroke Syndromes  
Infarct Location Clinical Features 
Posterior limb of internal capsule, 
crus cerebri midbrain or basis pontis  
Pure motor hemiparesis face, arm, 
leg, foot and toes are almost always 
involved. 
Ventrolateral thalamus Pure sensory stroke 
Base of the pons Ataxic hemiparesis 
Base of the pons or genu of the 
internal capsule 
Dysarthria and a clumsy hand or arm 
Genu and anterior limb of internal 
capsule and adjacent white matter of 
corona radiata 
Pure motor hemiparesis with motor 
aphasia  
 
 
 
 COMPUTED TOMOGRAPHY 
 CT was invented by Godfrey N. Hounsfield.  
 The typical radiation dose for a plain head CT is 40 to 60 milligray. 
Densities of various tissues in CT brain  
Tissue  Density (Hounsfield 
units) 
Gray Scale  
Air -1000 Black (↓↓↓) 
Fat -100 Black (↓↓) 
CSF 0 Black (↓) 
Brain  30 Gray (-) 
Extravasated Blood 100 White (↑↑) 
Contrast Medium 
Enhancement  
100 White (↑↑) 
Bone  1000 White (↑↑↑) 
Note:  
(↓↓↓) - marked hypoattenuation  (↓↓)- moderate hypoattenuation  
(↓) - mild hypoattenuation   (-) Isoattenuation to brain 
(↑↑) - moderate hyperattenuation  
(↑↑↑) - marked hyperattenuation. 
 An early CT is advisable in all stroke patients due to two reasons.  
a) To differentiate ischemic stroke from haemorrhage, as it could change 
the management.  
 b) To identify the presence of an underlying tumor, vascular 
malformation, haematoma that could mimic stroke. 
Though acute infarcts are more frequently visible on MRI than on CT, the 
latter is preferred as it is widely available, can be done on an emergency basis 
and it fulfills the basic needs for immediate management. Also patient 
cooperation is less of a problem in CT. Contrast enhancement on CT helps to 
pick up additional cases of acute infarction by showing relative hypodensity of 
involved area as compared to normal enhancing brain or by showing evidence of 
luxury perfusion.  
 It is also essential in patients with stroke who may require treatment with 
tissue plasminogen activator.  
 CT is also helpful in identifying patients at higher risk for haemorrhage. If 
an infarction is clearly visible and is atleast one half the size of the MCA 
territory, then the age of the infarct is likely to be >3 hrs or severe damage has 
already occurred. In such patients the risk of haemorrhage is high and these 
patients should not be treated with tissue plasminogen activator.  
 CT scan exposes the patient to minimal radiation and can be repeated if 
there is clinical suspicion of new infarction or recurrent haemorrhage (or) 
haemorrhage into an infarct (especially in patient on anticoagulation therapy). 
CT findings in cerebral infarction 
 State Findings 
Hyperacute (<12 hrs) Normal (50-60%) 
Hyperdense artery (25-50%) 
Obscuration of lentiform nuclei 
Acute (12-24 hrs) Low density basal ganglia 
Loss of grey-white matter interface 
(insular ribbon sign) 
Sulcal effacement  
1-3days Mass effect  
Wedge shaped low density area 
involving grey and white matter. 
Haemorrhagic transformation, gyral 
enhancement  
4-7 days  Gyral enhancement  
Mass effect, edema persists 
1-7weeks Contrast enhancement persists  
Mass effect resolves  
Months to years Encephalomalacic change, 
Volume loss 
Rarely calcification  
Early signs of cerebral edema 
a. Effacement of sulci and the sylvian fissure  
b. Decrease in size of the ipsilateral ventricle.  
 Cerebral edema involves both the gray and white matter and is restricted 
to the zone of infarction. The edema pattern may be helpful in differentiation 
from brain tumor which rarely involves the gray matter.  
 The use of contrast agents may be necessary when the diagnosis is 
unclear or a neoplasm is suspected. Contrast agents must be used only in 
selected cases as they may adversely affect prognosis or increase edema.  
 CT brain in Intracerebral haemorrhage  
 Among laboratory methods for the diagnosis of intracerebral 
haemorrhage the CT scan occupies the foremost position. This procedure has 
proved totally reliable in the detection of haemorrhages that are 1.0 cm or more 
in diameter.  
 If the volume of haematoma from CT is less than 30 ml it favours a better 
outcome. If volume of haematoma calculated from the CT brain is ≥ 60 ml the 
prognosis is poor. 
 Lacunar infarcts in internal capsule, thalamus, brainstem and cerebellum 
are difficult to be detected by CT. 
 The major limitation of CT is in the posterior fossa where linear artifacts 
appear because bone selectively attenuates the X-ray beam. The resulting beam 
hardening creates dense or lucent streaks that project across the brainstem and 
may obscure underlying lesions. 
 Helical CT can be done in an uncooperative patient as time require to 
perform it is less. There is some loss of resolution with this technique as 
scanning time decrease such that in routine brain imaging for stroke patients, 
helical scanning is not employed.  
MAGNETIC RESONANCE IMAGING (MRI) 
 MRI offers greater sensitivity and specificity in the detection of acute 
infarcts than CT. This is due to its substantially better soft tissue resolution, 
 grey-white matter differentiation and its ability to image in multiple planes. MRI 
is usually not indicated for emergency diagnosis, reasons being : 
• Not easily available  
• Monitoring of ill patients difficult within the MRI machine 
• Time required to perform MRI is greater than CT 
• Acute SAH can be easily missed on MRI. 
MRI is presently used where available as a problem solving modality and 
is specifically useful in the diagnosis of ischemic stroke involving brainstem and 
cerebellum. MRI is preferred as the first modality in patients with suspected 
posterior fossa infarcts and in patients with TIAs. 
 MRI Findings in Cerebral Infarction 
State Findings 
Immediate  Intravascular contrast enhancement 
Alteration of perfusion-diffusion  
co-efficient.  
< 12 hrs Anatomic changes of T1 images (gyral 
thickening, sulcal effacement, loss of grey 
white interface). 
12-24 hrs Hyperintensity, mass effect, Leptomeningeal 
enhancement  
1-3 days Obvious abnormality on T1, T2 images (early 
parenchymal contrast enhancement, 
haemorrhagic transformation). 
4-7 days Parenchymal enhancement haemorrhage 25% 
1-8 weeks Mass effect resolves, 
Decreased signal on T2 images enhancement 
persists  
Haemorrhagic signal evolves  
Months to years Encephalomalacic changes, volume loss, 
Haemosiderin staining  
 ELECTROCARDIOGRAPHIC CHANGES IN STROKE 
 Cardiovascular regulation is carried out by descending pathways from 
forebrain which converge in hypothalamus, hence cerebrovascular accident can 
produce changes in the ECG. These changes are often misdiagnosed as organic. 
Stroke can cause ST elevation or depression and ‘Q’ waves but plasma CPK 
levels do not rise. These changes normalize in 2 weeks time. Commonest 
changes observed are T wave inversion, sinus tachycardia. Other changes 
include ST depression, sinus QT prolongation, conduction disturbances and 
ectopic rhythms.  
THROMBOLYTIC THERAPY IN STROKE 
 In the recent years, the use of thrombolytic therapy in cerebral infarction 
has been studied extensively66. The European co-operative acute stroke study 
(ECASS) tested intravenous recombinant tissue plasminogen activator (rtPA : 
1.1 mg/kg to a max. 100 mg; 10% as bolus, the remainder over 60 min) within 6 
hrs of onset of symptoms.  
 The National institute of neurological disorders and stroke (NINDS) 
study tested rtPA(0.9 mg/kg to a 90 mg max; 10% as bolus and the remainder 
over 60 min) within 3 hours of onset of symptoms. Improved clinical outcome 
and decreased bleeding hazard observed in NINDS study was probably due to 
lower dose of rtPA and earlier institution of therapy.  
  A recent trial of the fibrinolytic agent ancrod in ischemic stroke is being 
evaluated. Recent trials PROACT I and II (Prolyse in acute cerebral 
thromboembolism) using intra-arterial thrombolysis upto the sixth hour showed 
benefit. However intra-arterial thrombolysis is not approved by the FDA and 
remains experimental.  
REHABILITATION 
 Proper rehabilitation of stroke patient includes, early physical, 
occupational and speech therapy. It is directed towards educating the patient and 
family about the neurological deficit, preventing complications of immobility, 
and providing encouragement and instruction in overcoming the deficit. The 
goal of rehabilitation is to return the patient to home early and to maximize 
recovery by providing a safe regimen suited to the individual patient.  
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 MATERIALS AND METHODS 
 Patients with cerebrovascular accident satisfying the inclusion criteria, 
admitted in our hospital during the period from January 2005 to December 2005 
were studied.  
Inclusion Criteria 
 Patients with a clinical diagnosis of stroke and on whom CT has been 
done were included. The various types of stroke in this group were: 
 Ischemic stroke 
 Haemorrhagic stroke  
o Intraparenchynal 
o Subarachnoid haemorrhage 
 Cortical vein thrombosis  
Exclusion Criteria 
 Neurological deficit lasting for less than 24 hrs.  
 Cases presenting 48 hrs after onset.  
 Space Occupying lesions 
 Subdural haemorrhage  
 Extradural haemorrhage 
 Patients with history of head injury. 
 Patients in whom CT Scan brain could not be performed.  
 A detailed history in each case regarding onset, predisposing factors and 
nature of stroke was recorded, followed by a thorough clinical examination.  
The major risk factors included in the study were hypertension, diabetes 
mellitus, hyperlipidemia along with other factors such as age, sex, menopause, 
puerperium which were evaluated. History of TIA was noted. In young patients 
family history of stroke and history of exposure to sexually transmitted disease 
were recorded. Habituations to smoking, alcohol was noted. Special clinical 
evaluation of cardiovascular system giving importance to rhythm disturbances, 
cardiac failure, valvular heart disease, prosthetic valve was made.  
Clinical neurological examination was done and the patients were 
grouped into those having cortical involvement, internal capsular involvement or 
brainstem involvement delineating the major blood vessels involved in the 
process. Ophthalmoscopic examination of the fundus was done. Patients with 
blood pressure readings of  ≥160/90 mm Hg on two occasions was taken as 
hypertension. 
Baseline investigations included complete blood count, blood sugar, urea, 
creatinine, electrolytes, cholesterol, urine analysis and chest x-ray. ECG was 
taken at admission, after 3 days and at discharge. CT Brain was done for all 
patients. Echocardiography and CSF analysis were done in relevant cases.  
The results of all data are expressed in tabular forms for analysis. For the 
analysis of ECG, those patients giving a definite history or evidence of diabetes 
 mellitus, coronary artery disease, rheumatic heart diseases, electrolyte 
disturbances or those on anti-arrhythmatic drugs were avoided.  
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TABLE – 1 
AGE DISTRIBUTION 
Age in Year Number (n=100) Percentage 
< 30 8 8 
31 – 50 22 22 
51 - 60 30 30 
> 61 40 40 
 
TABLE – 2 
SEX DISTRIBUTION 
Age in Year Male Female  
Less than 50 15 15 
More than 50 47 23 
Total 62 38 
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 TABLE – 3 
RISK FACTORS IN STROKE 
S.No. Risk Factors Number Percentage 
1. Systemic Hypertension 54 54 
2. Diabetes Mellitus 26 26 
3. Smoking 45 45 
4. Alcohol 34 34 
5. Heart Disease 26 26 
6. Hypercholesterolemia 12 12 
7. Transient Ischemic Attack 14 14 
8. Infection 1 1 
9. Vasculitis  1 1 
10. Aneurysm 1 1 
11. Uncertain cause 4 4 
 
TABLE – 4 
INCIDENCE OF CARDIAC DISEASES ASSOCIATED WITH STROKE  
Disease Number (n=26) Percentage 
Coronary Artery Disease 15 57.7 
Rheumatic Heart Disease 7 26.9 
Mitral Valve Prolapse 4 15.4 
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TABLE – 5 
CLINICAL PRESENTATION 
S.No. Factors  Number Percentage 
1. Hemiparesis 91 91 
2. Cranial nerve Involvement 89 89 
3. Aphasia 31 31 
4. Loss of consciousness 26 26 
5. Sensory symptoms 7 7 
6. Cerebellar 3 3 
7. Headache 14 14 
8. Vomiting 23 23 
9. Convulsions  5 5 
 
TABLE – 6 
APHASIAS 
Factors 
Number 
(n=31) Percentage 
Global 22 71 
Motor 7 22.6 
Sensory 2 6.4 
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 TABLE 7 
TIME OF OCCURRENCE OF STROKE 
Thrombotic 
(n=70) Embolic (n=12) 
Haemorrhagic 
(n=18) Time 
No % No % No % 
4 am – 8 am 31 44.3 5 41.7 8 44.4 
8 am – 12 pm 10 14.3 4 33.3 4 22.2 
12 pm - 4 am 29 41.4 3 25.0 6 33.3 
 
TABLE 8 
SIGNIFICANCE OF ACTIVITY  
Activity Sleep 
Factor 
No % No % 
Thrombotic (n=70) 30 42.9 40 57.1 
Embolic (n=12) 9 75 3 25.0 
Haemorrhagic (n=18) 14 77.8 4 22.2 
 
TABLE 9 
NATURE OF STROKE 
S.No. Stroke No Percentage 
1. Ischemic 82 82 
2. Haemorrhagic 18 18 
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TABLE 10 
AREA OF THE BRAIN INVOLVED IN ISCHEMIC STROKE 
S.No. Factor No Percentage  
1. Subcortical 42 51.2 
2. Cortical 25 30.5 
3. Cortical and Subcortical 13 15.9 
4. Brainstem /Cerebellar 2 2.4 
 
TABLE 11 
DISTRIBUTION OF ARTERIAL TERRITORY IN ISCHEMC STROKE 
S.No. Artery Involved 
No 
(n=82) Percentage 
1. MCA 73 89 
2. PCA 4 4.9 
3. Multiple 2 2.4 
4. MCA, PCA 1 1.2 
5. MCA, ACA 1 1.2 
6. ACA 1 1.2 
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 TABLE 12 
LOCATION OF HAEMORRHAGE 
S.No. Factor  No (n=18) Percentage 
1. Putamen 7 38.9 
2. Cortical 4 22.2 
3. Putamen, Thalamus 3 16.7 
4. Pons 2 11.1 
5. Cerebellum 1 5.5 
6. Subarachnoid Haemorrhage 1 5.5 
 
TABLE 13 
ECG CHANGES IN STROKE 
S.No. ECG No (n=25) Percentage 
1. T wave Inversion 10 40 
2. Sinus Tachycardia 8 32 
3. Sinus Bradycardia 4 16 
4. ST Depression 3 12 
5. Conduction Disturbance 2 8 
6. VPC 1 4 
7. Normal 2 8 
TABLE 14 
LEVEL OF CONSCIOUSNESS AND PROGNOSIS 
LOC (n=26) Death 
Factor 
No % No % 
Ischemic Stroke 11 42.3 5 45.5 
Haemorrhagic Stroke 15 57.7 13 86.7 
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 ANALYSIS OF DATA AND DISCUSSION  
Age 
 The maximum incidence of stroke in this study was observed in the above 
60 yrs age group (40%). According to Banford and Sandercock et al., 1987, 
maximum incidence of stroke was in the above 70 years age group. The 
Framingham study (1979) showed that 80% of patients, were above 65 years of 
age. Compared to Framingham study, a lower incidence of stroke in this study 
could be explained by: 
• Many cases of old stroke not being brought to the hospital. 
• A high mortality rate in cases of old stroke.  
• Higher prevalence of rheumatic heart disease in India compared to 
western population.  
• Majority of young strokes being hospitalized.  
In this study incidence of stroke in below 50 years age group was 30%, 
and above 50 yrs age group was 70%. This corelates well with the Vellore study 
by Abraham J. Inbaraj et al., where the incidence below 40 years was 27% and 
above 40 years was 73%, and the Rohtak rural study, where the prevalence of 
stroke below 40 yrs, was 28.8%. However in the Kashmir rural study, the 
prevalence below 40 years was 41.1% (Koul RL et al.). 
Sex 
  With regard to sex distribution, the male to female ratio in this study was 
1.6:1. In the below 50 years age, ratio was equal and in the above 50 years age 
group ratio was 2:1. Higher female preponderance in the younger age group 
could be attributed to higher prevalence of rheumatic heart disease.  
 In a study by Das Gupta et al., in 1984 male to female ratio was 1.3 : 1, 
which is almost similar to this study67. In the Madurai study by Aleem MA et al., 
1996, the male to female ratio in young strokes was 1.1:1, which corelates well 
with this study68. Study done by Jotideb Mukhopadhyay et al., 1998, concluded 
an equal incidence in males and females69. 
 An epidemiological study by K.R. Dhamija et al., 1998, recorded a male 
to female ratio of 1.7 : 1, which is in accordance with this study70. In a study 
published in Kashmir (1989), males constituted 64% of stroke patients. In the 
Saudi study by Qari FA et al., 2000, the male to female ratio was 3.4:1. 
 RISK FACTORS 
(i) Systemic Hypertension 
 Hypertension was the commonest predisposing factor in this study, 
present in 54% of the patients. Among the patients with haemorrhagic stroke, 
77.8% were hypertensives. The Framingham 18 years follow up study shows 
that hypertension was the most powerful precursor of stroke in both infarction 
and haemorrhage, which tallies with this study. In a population study of stroke 
patients in Richmond by Williams CA et al., 2003, 58.3% of patients were 
hypertensives, which corelates well with this study71. In Oxford Shire 
community stroke project, hypertension was present in 52% patients and Review 
of stroke studies by Dalal and Dalal gives a figure of 51%, which is similar to 
this study. 
 In a study by Rahman KMN et al., 2002, 78.82% of stroke patients were 
hypertensives72, and a study by Aszal C et al., 2002, documented hypertension in 
75% of patients73. Risk factors analysis by Jotideb et al., recorded 76% as 
hypertensives69, while an epidemiological study by K.R. Dhamija et al., showed 
34.7% as hypertensives70. Studies by Nielson W.B. et al., and Hart CL et al., 
2002 state that elevation of both systolic and diastolic blood pressure is 
associated with increased risk of stroke74. 
ii) Diabetes Mellitus 
  Diabetes mellitus was present in 26% of stroke patients in this study. In 
the Oxford Shire community stroke project, the incidence of diabetes mellitus in 
stroke was 28% which corelates well with this study. According to a study 
Manorama Devi in. “The incidence of stroke among Indian Nationals in UAE” 
diabetes was present in 20% of patients.  
 The incidence and severity of stroke are increased by the presence of 
diabetes and the outcome from stroke are poorer, according to a study by Baird 
TA et al., 200275. Study by Wannamathe et al., 1999 confirms diabetes mellitus 
as an independent risk factor for stroke76. Similar conclusions were drawn from 
the study of Hark CL et al., in 20009. 
iii. Smoking 
 Smoking was a risk factor in 45% of patients in this study. None of the 
females were smokers. According to a study by Williams CA et al., 2003, 33.3% 
of ischemic stroke patients and 26.3% of haemorrhagic stroke patients were 
smokers71. In a study by Ansari K et al., 2001, 29% of elderly stroke patients 
were smokers. Study on multiple cerebral infarcts by B Reddy et al., recorded a 
figure of 62%77. 
 Christensen et al., 2001, concluded that stroke patients who smoke are on 
an average nine years younger than non-smokers78. Study done by Bonita R et 
al., 1999 demonstrated that active as well as passive smoking increases the risk 
of stroke79. 
 iv. Alcohol consumption 
 Alcohol consumption was present in 34% of patients in this study. Study 
done by William CA et al., 2003 concluded that 41.6% of ischemic stroke 
patients and 21.1% of haemorrhagic stroke patients were alcoholics71. A study 
on multiple cerebral infarcts done by B Reddy et al., showed 30% of stroke 
patients were alcoholics77. 
 Studies by Reynolds K et al., 200380 and Wannamathe SG et al., 1996 
state that light or moderate alcohol consumption may be protective, while heavy 
alcohol consumption increases risk of stroke largely mediated through blood 
pressure76. Relationship of alcohol and stroke can be due to non-valvular atrial 
fibrillation or cardiomyopathy (Lancet – 1995). 
v. Heart disease 
 26% of patients in this study had cardiac disease associated with stroke. 
Among the cardiac diseases, coronary artery disease was present in 15 patients 
(57.7%), rheumatic heart disease in 7 patients (26.9%) and mitral valve prolapse 
in 4 patients (15.4%). Study by Ansari K et al., 2001, showed that 23% of stroke 
patients had cardiac disease. Studies by B Reddy et al.,77 Kundu TN et al.,81 
Aleem M.A. et al.,68 documented an incidence of 36%, 35% and 30.8% 
respectively. 
 The incidence of cardiac causes of embolic stroke in this study was 11%, 
of which 7% contributed by rheumatic heart disease with atrial fibrillation and 
 4% mitral valve prolapse with infective endocarditis. This shows that rheumatic 
heart disease with atrial fibrillation is the predominant cause of cardioembolic 
stroke. This is in accordance with studies by V.K. Gupta in Kashmir and A. 
Panagriya, Jaipur et al., 
 The incidence of coronary artery disease in stroke patients in this study 
was 15%. Among them, one patient developed stroke 4 days after the onset of 
acute myocardial infarction. Studies by Mooe T et al., 199982 and Errikcson P et 
al.,83 1997 state that the risk for stroke is highest in the first 5 days after 
myocardial infarction, predictors being atrial fibrillation, ST elevation and 
previous stroke. A study by Loh E et al. 1997, state that decreased ejection 
fraction and older age are predictors for risk, while anti-coagulation appears to 
have a protective effect against stroke after acute myocardial infarction84. 
 
vi. Hypercholesterolemia 
 In this study 12% of patients had elevated total cholesterol levels, 
indicating a causal relationship between stroke and lipid profile. Similar 
observations were also made by Shridharan, Apollo Hospitals, Chennai, H. 
Jacobs, D.R. Wentworth (1999), and Prospective studies collaboration the 
Lancet 199585. The literature does not give a clear relation between serum lipids 
and stroke. Studies by NA Rajwade et al., (1996)86 Sarti C et al., (2000)87 state 
that the lipid levels in stroke patients were observed to be higher but not 
 significant and their associations are relatively weak. A study by Wannamathe 
SG et al., (2000) concludes that elevated total cholesterol showed a weak 
positive association, while elevated HDL cholesterol was associated with a 
significant decrease in the risk of stroke88. However studies by Nair  
M. Radhakrishnan et al., at Kerala and Jotideb et al., West Bengal, suggested 
that hyperlipidemia is an important risk factor for stroke69. It may be concluded 
that hypercholesterolemia is a risk factor for stroke, although the risk imparted is 
lower than that for myocardial infarction.  
vii. Transient Ischemic Attack and Other Factors 
 In this study, past history of stroke or Transient ischemic attacks were 
present in 14% of patients. According to a study by William CA et al. (2003) 
history of prior neurovascular disease was present in 36.2%71. MM Singh et al., 
(1996) in his study stated that transient ischemic attack is associated with mild to 
moderate stenosis of internal carotid artery and is an important predictor of 
ischemic stroke. Other etiological factors in this study include infective 
endocarditis, tuberculous meningitis and subarachnoid haemorrhage secondary 
to aneurysms.  
CLINICAL PRESENTATION 
• Hemiparesis was the commonest presentation in this study, present in 
91% of patients. This is in accordance with the study by Rahman KM et 
al., (2002) where hemiplegia was present in 88.24%72. 
 • 26% of patients presented with loss of consciousness. 83.3% of 
haemorrhagic stroke patients and 22% of ischemic stroke patients had 
altered consciousness level. Study by Rahman KM et al., suggested that 
54.84% of haemorrhagic stroke patients present with altered 
consciousness72. 
• Headache and vomiting were present in 14 and 23 patients respectively. 
Incidence of headache and vomiting were more in the haemorrhagic 
stroke patients and among the ischemic stroke patients, it was more 
common in posterior circulation stroke.  
• 5 patients presented with convulsions, out of which 2 had embolic stroke, 
1 patient had thrombotic stroke in the cortical territory and 2 had 
haemorrhagic stroke.  
• Language disturbances were observed in 31 patients. 22 had global 
aphasia, 7 had motor aphasia and 2 patients had sensory aphasia. These 
presentations correlated well with involvement of cortical territory. 
• 7 patients had sensory disturbances, out of which 3 had thalamic infarct, 
one patient had thalamic haemorrhage, one had lateral medullary 
syndrome, one had brainstem stroke and one cortical infarct.  
• Cerebellar involvement was observed in 3 patients. One had lateral 
medullary syndrome, one had cerebellar haemorrhage and the last one had 
brainstem stroke with cerebellar involvement.  
Time of occurrence 
  In this study, 44.3% of thrombotic stokes, 41.7% of embolic strokes and 
44.4% of haemorrhagic strokes occurred in the early morning hours between 4 
am and 8 am. A study by Lago A et al., (1998) observed a higher frequency of 
strokes during the day and lower frequency in the last hours of the evening in all 
types of stroke, which is in accordance with this study89. Similar observations, 
were made by Chaturvedi S. et al., (1999)90 and Casetta I et al., (2002) in 
ischemic stroke91. They suggest the circadian variability in blood pressure and a 
concurrent morning hypercoagulability as possible determinants of this pattern.  
 57.1% of thrombotic strokes occur during sleep (40% in Michael Reel 
Stroke Registry)92. 75% of embolic strokes and 77.8% of haemorrhagic strokes 
occurred during activity in this study (68% and 64% respectively in Michael 
Reel stroke registry). 
CT SCAN CORRELATION  
• CT scan is the single most important non invasive investigation to 
distinguish infarction from cerebral haemorrhage.  
• After 6 hrs, CT brain may show lesion in <1/3 of patients with cerebral 
infarct and at 12 hrs 50% show evidence of infarction. Over 90% 
supratentorial infarctions (moderate to large) can be detected within 24 
hrs.  
• In this study, out of the 100 patients studied, CT Scan showed ischemic 
stroke in 82% and haemorrhage in 18%. Studies by K.R.Dhamija et al., 
 (1998)70 and Quari FA et al., (2000) observed cerebral infarction in 
82.6% and 77% respectively, which tallies with this study. 
• Regarding the distribution of arterial territory in ischemic stroke, MCA 
was involved in 89%, PCA in 4.9%, ACA in 1.2%. Involvement of more 
than one arterial territory was observed in 4.8%. Study by K. Srinivasa 
Rao et al., documented 54% in the MCA, 4.5% in the PCA, 4.5% in the 
ACA, and 27% at multiple sites.  
• With respect to the area of the brain involved in ischemic stroke, 51.2% 
had subcortical and 30.5% cortical infarcts, combination of both was 
observed in 15.9%. Brainstem and cerebellar lesions found in 2.4%. In a 
study by Sandya Purohit et al., (1999) cortical infarcts were found in 
18%. 
• Among the 18 patients with haemorrhagic stroke, 7 patients had putamen 
haemorrhage (38.9%), cortical haemorrhage in 4 (22.2%), thalamic 
haemorrhage in 3 (16.7%). 2 patients had pontine haemorrhage and both 
of them expired. Cerebellar and subarachnoid haemorrhage were 
documented in one patient each. According to a study by K. Srinivasa 
Rao et al., (1998), 40% haemorrhages occurred in basal ganglia, and 27% 
in the thalamic region.  
• Among laboratory methods for diagnosis of intracerebral haemorrhage 
the CT scan occupies the foremost position. This procedure has proved 
totally reliable in the detection of haemorrhages that are 1.0 cm or more 
in diameter. If the volume of haematoma from CT is less than 30ml it 
 favours a better prognosis. If volume of haematoma calculated from the 
CT brain is ≥ 60 ml the prognosis is poor.  
• The distinct appearance of the fresh haemorrhage changes with time, 
disappearing slowly in the subsequent days to weeks, depending on the 
size of the haemorrhage. Thereafter the haemorrhage appears as a region 
of low densities on CT scan, which can be mistaken for an old infarct. So 
if CT imaging is delayed for more than a few weeks after stroke, it may 
not possible to reliably distinguish between ischemic and haemorrhagic 
stroke  
• Hypertension was the commonest predisposing factor in this study, 
present in 54% of patients. Among patients with haemorrhagic stroke as 
evidenced by CT scan 86.6% of them were hypertensives.  
• Diabetes mellitus was present in 26% of stroke patients in this study. 
Among the patients with diabetes mellitus CT scan showed increased 
incidence of infarct than haemorrhage. 
• Other important risk factors such as alcohol consumption, 
hypercholesterolemia, TIA were present in 34%, 12%, 14% of the 
patients respectively: with CT scan showing increased preponderance to 
infarct pattern.  
• Cardiac causes namely RHD, MVPS increases the incidence of ischemic 
embolic stroke which in this study was 11% as shown by the infarcts in 
CT scan. 
 • Haemorrhagic stroke as evidenced from CT scan showed increased 
incidence of headache and vomiting. However among the infarct patients 
it was more associated with posterior circulation strokes.  
• Convulsions occurred in 11% of patients with haemorrhagic stroke and 
0.4% of ischemic stroke. Among the patients with ischemic strokes 
convulsions was more common in cortical infarcts.  
• Among the haemorrhagic stroke revealed by CT scan, 83.3% presented 
with loss of consciousness where as it was 22% in ischemic stroke.  
• Sensory disturbances were more common in patients with thalamic and 
cortical infarcts as revealed by CT scan.  
• Patients with language disturbances had more incidence of cortical 
territory infarct in CT scan.  
• In this study, CT scan showed cerebellar involvement in 3 patients, one 
had lateral medullary syndrome, one had cerebellar haemorrhage and 
other one had brainstem stroke with cerebellar involvement. 
ECG CHANGES IN STROKE 
 For the analysis of ECG, patients with coronary artery disease, rheumatic 
heart disease, those with definite history of diabetes and hypertension, renal 
failure patients, those on anti-arrythmic drugs were excluded. Out of the 100 
patients, 25 satisfying the criteria were selected and their ECGs were analysed.  
 The commonest change observed was T wave inversion and sinus 
tachycardia present in 40% and 32% respectively. Sinus bradycardia in 16% and 
 ST depression in 12%. 8% had conduction disturbance, Ventricular premature 
contractions observed in 4% and 8% had normal ECG. 
 PROGNOSIS 
 Loss of consciousness at the time of admission is considered to be an 
adverse prognostic factor. In this study, 5 out of the 11 ischemic stroke patients 
and 13 out of the 15 haemorrhagic stroke patients, presenting with loss of 
consciousness expired. On an average, 69.2% of patients presenting with loss of 
consciousness died. Studies of M Das et al., (1999) and IS Gambhir et al., (1998) 
state that level of consciousness at admission by Glasgow coma scale is a very 
important prognostic factor and 82.14% of patients with a score less than 8 
expired.  
 Similar observations were made by Gambir IS et al.,93 (1998) and Joshi 
PP et al ., (1999)94. Study by Masquardsen et al., states that nearly all patients 
who were deeply comatosed at the time of admission died within 24 hrs. 
Semicomatosed patients also fared badly. The above results were comparable to 
this study. 
  
 
 
 
 
 
Conclusi
on 
 CONCLUSIONS 
• The risk factors were present in more than 90% of cases. 
• The incidence of stroke was more common in the above 60 years age 
group. 
• The incidence in males was one and a half times more than in the females, 
with the difference being negligible or absent in the less than 50. This is 
attributed to increased prevalence of rheumatic heart disease in young 
females.  
• Hypertension was the commonest risk factor in both ischemic and 
haemorrhagic strokes, present in more than half of the patients, followed 
by smoking, and diabetes mellitus.  
• There is a weak positive association between hypercholesterolemia and 
stroke.  
• Heart disease was the predominant risk factor in the young, of which 
rheumatic mitral stenosis with atrial fibrillation was found to be the most 
common, followed by mitral valve prolapse with infective endocarditis. 
• The presence of atherosclerosis increases the risk of stroke.  
• Risk for ischemic stroke doubles for smokers. In smokers, stroke occurs 
after an average of 10-20 years of smoking. 
• Only about 12% of patients experienced transient ischemic attack. 
• Other important causes of stroke in the young were vasculitis and 
aneurysmal rupture.  
 • Hemiparesis was the commonest presenting feature in both ischemic and 
haemorrhagic stroke followed by cranial nerve involvement, aphasia and 
loss of consciousness.  
• Headache and vomiting were more common in haemorrhagic stroke. In 
ischemic stroke, it was more common in the posterior circulation stroke. 
• Convulsions were more common in embolic stroke involving cortical 
territory. 
• Peak incidence of stroke occurred between 4 am to 8 am irrespective of 
the type of stroke. 
• More than half of thrombotic strokes occur during sleep. Nearly three 
fourths of embolic and haemorrhagic strokes occur during activity.  
• Majority of strokes were found to be infarcts, commonest being the 
middle cerebral artery territory followed by posterior cerebral artery.  
• Among ischemic strokes, involvement of sub-cortical structures i.e. 
Internal capsule, putamen, basal ganglia were more common compared to 
cortical structure.  
• Among haemorrhagic strokes, putamen involvement was the commonest 
followed by cortical haemorrhage.  
• Commonest ECG change observed was T wave inversion and sinus 
tachycardia.  
• Loss of consciousness is an adverse prognostic factor with a mortality rate 
of 69%. 
 • Computed Tomography is likely to remain the principal imaging 
technique for stroke patients in foreseeable future, not only because it 
excludes several non-stroke pathologies and reliably distinguishes 
haemorrhage from infarction, but because it is far more widely available, 
relatively less expensive, easier and safer to use in acutely ill stroke 
patients.  
• CT scan is also essential in patients with stroke who require thrombolytic 
treatment with tissue plasminogen activator.  
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Proforma 
 PROFORMA 
Name  :    Study No. : 
Age/Sex :    IP No. : 
Occupation :    DOA  : 
Place  :    DOD  : 
 
HISTORY 
PRESENT HISTORY 
• Weakness of limbs 
• Sensory disturbance 
• Cranial Nerve palsies 
• Language disturbance Global / Motor / Sensory aphasia 
• Memory disturbance  
• Cerebellar symptoms  
• Headache, Vomiting, Convulsions 
• Loss of Consciousness 
• Autonomic nervous system symptoms 
• Activity/ Sleep, Time of onset  
• Trauma, Fever 
 
PAST HISTORY 
 
• Transient ischemic attack 
• Stroke 
• Diabetes mellitus 
• Systemic hypertension 
• CAD 
• Rheumatic heart disease 
• Intermittent claudication 
• H/O oral contraceptive intake  
 
FAMILY HISTORY 
 
 Stroke / Diabetes mellitus / Systemic hypertension / CAD 
 
PERSONAL HISTORY 
 
• Smoker  - / Day  Years 
• Alcoholic  - / Day  Years 
 
MENSTRUAL HISTORY 
 
• Pre – Menopausal 
• Post – Menopausal 
GENERAL EXAMINATION 
  Febrile / Afebrile  Anemia / Cyanosis / Clubbing / Pedal edema. 
 
Pulse  :    Peripheral pulses  : 
BP   :    Respiration  : 
CVS  : S1 S2, murmurs 
RS  : NVBS , added sounds  
P/A  : Bowel sounds, organomegaly  
 
CNS 
•   Handedness  • Conscious/Semi–conscious / Unconsciousness  
•   Orientation  • Speech-Normal/Aphasia-Global/Motor/Sensory 
•   Cranial nerve palsies • Motor weakness 
•   Sensory abnormalities • Cerebellum 
•   Carotids   •  Fundus 
•   Gait  •   Involuntary movements 
•   Signs of meningeal irritation  
 
CLINICAL DIAGNOSIS: 
 
 
INVESTIGATIONS 
 
TC   DC   Hb% 
PCV   ESR   Platelet count 
Blood -  Sugar    
   Urea    Urine Complete 
   Creatinine 
   Electrolytes  CSF analysis  
Serum Cholesterol 
Chest X-ray  ECG 
CT Brain  MRI 
Echocardiography Carotid Doppler 
 
 
FINAL DIAGNOSIS: 
 
  
 
 
 
 
 
 
 
 
 
 
 
Abbrevia
tions 
 ABBREVIATIONS 
 
 
ACA  - Anterior Cerebral Artery 
AF  - Atrial Fibrillation 
ASMI  - Anteroseptal Myocardial Infarction  
BG  - Basal Ganglia 
BS  - Brainstem 
C  - Cortical 
CAD  - Coronary Artery Disease 
CHO  - Serum Cholesterol 
CN  - Cranial Nerve 
CT  - Computed Tomography 
DIC  - Disseminated Intravascular Coagulation 
DM  - Diabetes Mellitus 
E  - Expired 
ECG  - Electrocardiogram 
ECHO - Echocardiogram  
EM  - Embolic 
G  - Global Aphasia 
H  - Haemorrhage 
I  - Infarction 
IE  - Infective Endocarditis 
IVCD  - Intra Ventricular Conduction Defect 
IWMI  - Inferior Wall Myocardial Infarction 
LH  - Left Hemiparesis 
LMS  - Lateral Medullary Syndrome  
LOC  - Loss of Consciousness 
M  - Motor Aphasia 
MCA  - Middle Cerebral Artery 
MI  - Myocardial Infarction  
MR  - Mitral Regurgitation 
 MS  - Mitral Stenosis 
MVP  - Mitral Valve Prolapse 
N  - Normal 
P  - Putamen 
PCA  - Posterior Cerebral Artery 
PH  - Past History of Stroke 
PHT  - Pulmonary Hypertension  
R  - Recovered 
RBBB - Right Bundle Branch Block 
RH  - Right Hemiparesis 
RHD  - Rheumatic Heart Disease 
S  - Sensory Aphasia 
SAH  - Sub Arachnoid Haemorrhage 
SB  - Sinus Bradycardia 
SC  - Subcortical 
SHT  - Systemic Hypertension 
ST  - Sinus Tachycardia 
ST↓  - ST Depression 
T  - Thalamus 
T↓  - T wave Inversion 
TBM  - Tuberculous Meningitis 
Th  - Thrombotic 
TIA  - Transient Ischemic Attack 
VEG  - Vegetation 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Master 
Chart 
 MASTER CHART 
CT S.
No
. 
Age Sex 
Time 
of  
occurre
nce  
Activi
ty/ 
Sleep 
Weak 
ness 
Cranial 
Nerve Aphasia Sensory 
Headache   
/Vomiting LOC/Fits SHT/DM 
Smoking 
/Alcohol TIA/PH 
CAD 
/RHD CHO ECG ECHO 
Clinical  
Diagnosi
s I/H Artery 
Cortical/ 
Subcortic
al 
Outcome 
1 55 M 7.00PM S RH 7 - - - - DM S/A - - 120 T ↓ - I-TH I MCA SC R 
2 65 M 11.00PM S RH 7 G - - - SHT S/A - - 176 ST DD I-TH I MCA C,SC R 
3 50 M 3.00PM S LH 7 - - - - SHT S/A TIA - 133 ST - I-TH I MCA SC R 
4 58 M 4.00PM A LH 7 - - - - - S/A - - 225 VPC - I-TH I MCA C R 
5 85 F 7.00AM S LH 7 M - - - - - PH - 234 T↓ - I-TH I MCA SC R 
6 65 M 2.00PM A RH 7 G - - - - S - - 177 T↓ - I-TH I MCA C R 
7 45 F 2.00AM S RH 7 G - - LOC/F - - TIA/PH RHD 176 
RAD, 
LAE, 
AF 
MS. 
MR,  
PHT 
RHD,  
I-EM I MCA C E 
8 62 M 11.00PM S LH - - - - - SHT - PH - 142 ST - I-TH I MCA SC R 
9 68 F 9.00PM A LH - - - - - SHT/DM - - - 205 LVH - I-TH I MCA SC R 
10 48 M 3.00PM A RH 7 - - - - SHT - - - 136 N - I-TH I MCA SC R 
11 60 M 11.00AM A LH 7 - - H/V LOC SHT/DM S - - 148 IVCD, LVH - H H - P,T,IC E 
12 70 M 12.00AM S RH 7 - - - - SHT/DM - - - 153 N - I-TH H - P,BG,T,IC R 
13 36 F 12.00PM A RH 7 G - H - - - - - 172 LVH 
MVP, 
MR, 
VEG+ 
I-EM I MCA C,SC E 
14 70 F 11.00AM S RH 7 G - - F SHT/DM - - - 156 N - I-TH I MCA C R 
15 72 M 3.00PM A RH 7 - - V LOC SHT S/A - - 175 ST - H H - C E 
16 49 M 6.00AM A LH 7 - - V LOC SHT S/A - - 165 N - I-TH I MCA C R 
17 75 F 5.00AM A RH 7 - + - LOC SHT - - - 172 N DD, LVH I-TH H - P,BG,T,IC E 
18 60 M 6.00AM, S LH 7 - - - - SHT S - - 185 ST - I-TH I MCA SC R 
19 60 M 7.00AM A RH 7 G - - - SHT S/A - - 192 IVCD - I-TH I MCA SC R 
20 58 M 2.00PM S RH 7 G - - - - S - - 210 ST - I-TH I MCA C R 
21 54 M 9.00PM A RH 7 - - - - - S/A - - 175 SB - I-TH I MCA SC R 
22 81 M 9.00PM A LH 7 - - - LOC DM S/A - - 180 ST, ST ↓ - I-TH I MCA SC R 
 23 48 M 10.00AM A RH 7 - - - - - S - - 186 SB, LVH 
MVP, 
MR I-EM I MCA SC R 
24 70 F 7.00AM S LH 7 - - - - SHT - - - 157 N DD, LVH I-TH I MCA SC R 
25 78 F 2.00PM S RH 7 G - V - - - - - 142 T ↓ - I-TH I MCA C,SC R 
26 18 F 8.00AM S LH 7 G - H - - - - - 150 ST - I-TH-EBM I MCA C E 
27 65 F 7.00AM A LH 7 - - H LOC/F SHT - - - 126 N - H H - P,BG R 
28 52 M 8.00PM A Cerebell
ar 
9,10,5 - + H - SHT/DM S/A - - 134 N - I-TH I PCA LMS E 
29 50 M 6.00A A LH 7 - - V LOC SHT A - CAD 136 OLD IWMI - H H - P.BG E 
30 73 M 11.00PM A - - - + - LOC DM S/A - CAD 164 ST T - H I PCA C E 
31 75 M 10.00AM S RH 7 G - - - DM - - - 200 T ↓ - I-TH I MCA C R 
32 85 F 7.00AM S LH 7 - - - - SHT - - - 140 
LVH, 
ST, 
ST↓ 
DD, 
LVH I-TH I MCA SC R 
33 48 M 7.00AM S RH 7,12 - - - - SHT/DM S - - 188 N - I-TH I MCA SC R 
34 60 F 4.00PM A LH 7 - - V - SHT/DM - TIA - 136 ST - I-TH I ACA,MCA C R 
35 40 F 4.00PM A LH 7 - - - - - - - RHD 148 
LAD, 
AF, 
RBBB 
T 
MS, 
PHT 
I-EMB, 
RHD I MCA SC R 
36 80 F 6.00AM S LH 7 - - - - SHT - - CAD 150 LBBB LAD - I-TH I MCA SC R 
37 36 M 11.00AM S LH 7 - - - - - S/A - - 140 ST, T ↓ - I-TH I MCA SC R 
38 75 M 6.00 AM S RH 7 G - - - SHT/DM S/A - - 158 ST DD I-TH I MCA C,SC R 
39 60 F 6.00AM S - 7,8,9,10 - + - - SHT/DM - - - 174 T LVH - I-TH I PCA C,SC R 
40 60 F 6.00PM A Cerebell
ar 
- - - - - SHT/DM - - - 144 LVH - I-TH H - Cerebellar R 
41 80 F 8.00PM A LH 7 - - H LOC SHT - - - 196 T ST↓ - H H - SC-P, BG E 
42 60 F 4.00AM S LH 7 - - - - SHT - - - 198 N - I-TH I MCA SC R 
43 65 M 8.00PM A - - - - V LOC SHT S/A - - 174 LVH - H H - C E 
44 55 F 6.00AM S RH 7 S - - LOC SHT - - - 124 LVH - I-TH H - C E 
45 70 F 6.00AM S RH 7 - - - - SHT/DM - - - 176 ST DD I-TH I MCA SC R 
46 73 M 3.00AM S RH 7 - - - - SHT S - - 186 T↓ DD, LVH I-TH I MCA SC R 
47 52 M 10.00AM A RH 7 G - - - SHT/DM S - - 146 ST - I-TH I MCA C,SC R 
 48 58 M 3.00PM A LH 7 - - - - SHT S - - 152 ST - I-TH I MCA SC R 
49 55 F 10.00AM A LH 7 - - - - - - - - 164 T↓,  ST ↓ - I-TH I MCA SC R 
50 58 F 7.00AM S - - - - H/V LOC SHT/DM - PH - 178 ST T ST ↓ DD H I 
MCA, 
PCA C,SC E 
51 48 F 2.00PM A - - - - - LOC/F SHT - PH CAD 182 ST T - H H - PONTINE E 
52 45 M 8.00AM A RH 7 M - - - - S/A - - 234 
IVCD 
ST  
↓ RBBB 
- I-TH I MCA SC R 
53 55 M 6.00AM S LH 7 - - - - - S/A - - 114 SB - I-TH I MCA SC R 
54 64 M 2.00PM S RH 7 - - - - SHT - - - 163 T↓ DD I-TH I MCA SC R 
55 50 M 4.00PM S RH 7 G + - - - S/A - CAD 162 T↓ - I-TH I MCA C,SC R 
56 36 F 5.00AM A - - - - - LOC - - PH - 124 ST 
MVP, 
VEG+ 
AML 
I-EM, 
MVP IE I MCA C E 
57 53 M 5.00AM S RH 7 G - - LOC SHT S/A - CAD 134 ST, T↓ - I-TH I MCA C R 
58 65 M 8.00PM S LH 7 - - - - SHT S/A - - 208 N - I-TH I MCA SC R 
59 60 M 7.00PM S RH - - - - LOC DM S/A - - 222 RBBB - H H - PONTINE E 
60 20 F 6.00AM S RH 7 - - H/V - - - - RHD 154 
RAD, 
LAE, 
AF 
MS, 
PHT 
RHD,  
I-EM I MCA C E 
61 70 M 4.00AM S RH 7 G - - - SHT S/A - - 170 T↓ - I-TH I MCA C R 
62 75 M 4.00PM S RH 7 M - - - SHT S/A - - 128 T↓ DD, LVH I-TH I MCA C R 
63 55 M 6.00AM S LH 7 - - H - - S/A - - 182 ST, T↓ - I-TH I MCA SC R 
64 55 F 8.00AM A RH 7 S - - - SHT/DM - - - 194 IVCD - I-TH I MCA C R 
65 65 M 5.00AM S LH 7 - - - - DM - - - 136 ST, IVCD - I-TH I MCA SC R 
66 38 M 8.00AM A RH 7 M - - LOC SHT A - CAD 196 T↓ - I-TH I MCA C,SC R 
67 65 M 2.00PM A RH 7 - - - - SHT - - - 142 N - I-TH I MCA SC R 
68 40 F 4.00AM S LH 7 - - - - - - - - 210 N MVP, VEG+ 
I-EM, 
MVP IE I MCA SC E 
69 29 F 1.00PM A RH 7 - - V F - - PH RHD 156 
LAE, 
RAD,  
ST 
MS, 
PHT 
I-EM, 
RHD I MCA SC R 
70 30 F 2.00PM A LH 7 - - V - - - - RHD 132 
LAE, 
RAD, 
AF 
MS, 
MR 
I-EM, 
RHD I MCA SC R 
71 72 M 7.00AM S RH 7 G - - - SHT - - - 194 N - I-TH I MCA C R 
 72 80 M 8.00AM S LH 7 - - - - DM - - CAD 126 ST - I-TH I MCA SC R 
73 68 M 2.00PM A LH 7 - - V - SHT - - - 187 N DD I-TH I MCA SC R 
74 28 F 4.00PM A RH 7 G - V - - - - RHD 146 
LAE, 
RAD, 
AF 
MS RHD,  I-EM I MCA C E 
75 70 M 9.00PM A LH 7 - - - - DM - - CAD 134 T↓ - I-TH I MCA SC R 
76 74 M 8.00AM S RH 7 - - - - SHT - - - 158 DD - I-TH I MCA SC R 
77 30 F 6.00PM A LH 7 - - V - - - PH RHD 128 
RAD, 
LAE, 
AF 
MS,MR
,PHT 
RHD,  
I-EM I MCA SC R 
78 40 M 8.00AM A - - - - H/V LOC SHT S/A - - 148 N - H SAH - - E 
79 39 M 8.00AM S RH+Cer
ebellar 7,8,9,10 - + - - - S/A - CAD 136 ST - I I PCA BS E 
80 40 M 10.00AM A RH 7 M - - - DM S/A - CAD 160 T↓ - I-TH I MCA C R 
81 52 M 2.00AM A RH 7 M - - - DM S/A TIA CAD 145 ST, T↓ - I-TH I MCA C R 
82 73 M 1.00A S LH 7 - - H/V LOC SHT S PH - 134 ST, T↓ DD, LVH I-TH I 
MULTI
PLE C,SC E 
83 60 M 8.00PM A RH 7 G - - LOC SHT A - - 146 ST - I-TH I MCA C R 
84 42 M 4.00PM A LH 7 - - H/V LOC - - - - 154 ST↓ - I-TH H - C E 
85 60 M 5.00PM A RH 7 G - - - - S - - 183 T↓ - I-TH I MCA C R 
86 50 F 6.00AM A RH 7 - - V LOC SHT - - - 138 N - I-TH I MCA SC,C R 
87 62 F 8.00AM S RH 7 M - V - SHT - - - 152 T↓ - H I MCA C R 
88 50 M 12.00AM S RH 7 G + H/V - SHT S - - 170 LVH - I-TH I MULTIPLE C,SC E 
89 58 M 8.00AM A LH 7 - - - - - S - - 139 T↓ - I-EM I MCA SC R 
90 82 F 4.00AM S RH 7 - - V - SHT - - - 217 LVH DD, LVH I-TH H - P,BG R 
91 38 M 10.00PM A LH 7 - - - - - S - - 182 ST - I-TH I MCA SC R 
92 73 M 6.00AM A LH 7,6 - - - - SHT S - - 210 ST DD, LVH I-TH I MCA SC R 
93 60 M 6.00AM A LH 7 - - - - - S - - 163 T↓ - H I MCA SC R 
94 73 M 8.00AM A RH 7 - - V LOC DM S/A - CAD 161 ASMI - I-TH H - BG E 
95 68 M 6.00AM S RH 7 G - H/V - DM A PH CAD 145 ST - I-TH I MCA C,SC R 
96 60 M 11.00PM A RH - - - - - - A - CAD 174 T↓ - I-TH I ACA SC R 
97 30 F 10.00AM A RH 7 G - - LOC - - - - 132 T↓ - H H - P E 
 98 68 F 7.00AM A LH 7 - - - LOC SHT - - - 118 N - H H - P,BG R 
99 60 F 7.00PM S RH 7 - - - - - - - - 230 SB - I-TH I MCA SC R 
10
0 69 M 2.00PM A LH 7 - - - - - S/A TIA - 150 ST - I-TH I MCA C,SC R 
 
